1. Home
  2. POM vs CLGN Comparison

POM vs CLGN Comparison

Compare POM & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POMDOCTOR LIMITED American Depositary Shares

POM

POMDOCTOR LIMITED American Depositary Shares

SELL

Current Price

$1.80

Market Cap

5.9M

ML Signal

SELL

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

SELL

Current Price

$3.94

Market Cap

5.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
POM
CLGN
Founded
2015
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Other Specialty Stores
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
POM
CLGN
Price
$1.80
$3.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.1M
40.1K
Earning Date
11-10-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.26
52 Week High
$6.43
$4.78

Technical Indicators

Market Signals
Indicator
POM
CLGN
Relative Strength Index (RSI) 61.68 57.00
Support Level $0.28 $0.34
Resistance Level $1.78 $3.91
Average True Range (ATR) 0.46 0.35
MACD 0.08 -0.06
Stochastic Oscillator 48.35 45.19

Price Performance

Historical Comparison
POM
CLGN

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: